Quantitative Systematic Strategies’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,755
Closed -$341K – 618
2021
Q1
$341K Buy
1,755
+175
+11% +$35.9K 0.05% 451
2020
Q4
$303K Sell
1,580
-78
-5% -$14.2K 0.04% 483
2020
Q3
$245K Sell
1,658
-60
-3% -$8.58K 0.04% 487
2020
Q2
$212K Buy
+1,718
New +$202K 0.04% 502
2020
Q1
– Sell
-6,825
Closed -$631K – 478
2019
Q4
$631K Buy
+6,825
New +$573K 0.09% 291

Other funds holding RGEN

Quantitative Systematic Strategies's RGEN Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Repligen (RGEN) in Q2 2021, closing a stake of 1,755 shares — an estimated $341K sold.

Quantitative Systematic Strategies first reported a position in RGEN in Q4 2019 and held it in 5 quarters. The position peaked at $631K in Q4 2019. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 1,755 Repligen shares in Q2 2021, an estimated $341K.
  • Quantitative Systematic Strategies first reported a position in Repligen in Q4 2019 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Repligen position peaked at $631K in Q4 2019.
  • 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.